These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 7688786)

  • 41. CD40 cross-linking inhibits specific antibody production by human B cells.
    Callard RE; Herbert J; Smith SH; Armitage RJ; Costelloe KE
    Int Immunol; 1995 Nov; 7(11):1809-15. PubMed ID: 8580079
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enhancement of IgE production by anti-CD40 antibody in atopic dermatitis.
    Renz H; Brodie C; Bradley K; Leung DY; Gelfand EW
    J Allergy Clin Immunol; 1994 Mar; 93(3):658-68. PubMed ID: 7512104
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Involvement of LFA-1/intracellular adhesion molecule-1-dependent cell adhesion in CD40-mediated inhibition of human B lymphoma cell death induced by surface IgM crosslinking.
    Sumimoto S; Heike T; Kanazashi S; Shintaku N; Jung EY; Hata D; Katamura K; Mayumi M
    J Immunol; 1994 Sep; 153(6):2488-96. PubMed ID: 7521364
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal.
    Ranheim EA; Kipps TJ
    J Exp Med; 1993 Apr; 177(4):925-35. PubMed ID: 7681471
    [TBL] [Abstract][Full Text] [Related]  

  • 45. IL-2 and a contact-mediated signal provided by TCR alpha beta + or TCR gamma delta + CD4+ T cells induce polyclonal Ig production by committed human B cells. Enhancement by IL-5, specific inhibition of IgA synthesis by IL-4.
    van Vlasselaer P; Gascan H; de Waal Malefyt R; de Vries JE
    J Immunol; 1992 Mar; 148(6):1674-84. PubMed ID: 1347306
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Negative selection of human germinal center B cells by prolonged BCR cross-linking.
    Galibert L; Burdin N; Barthélémy C; Meffre G; Durand I; Garcia E; Garrone P; Rousset F; Banchereau J; Liu YJ
    J Exp Med; 1996 May; 183(5):2075-85. PubMed ID: 8642318
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular interactions mediating T-B lymphocyte collaboration in human lymphoid follicles. Roles of T cell-B-cell-activating molecule (5c8 antigen) and CD40 in contact-dependent help.
    Lederman S; Yellin MJ; Inghirami G; Lee JJ; Knowles DM; Chess L
    J Immunol; 1992 Dec; 149(12):3817-26. PubMed ID: 1281189
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes.
    Rousset F; Garcia E; Defrance T; Péronne C; Vezzio N; Hsu DH; Kastelein R; Moore KW; Banchereau J
    Proc Natl Acad Sci U S A; 1992 Mar; 89(5):1890-3. PubMed ID: 1371884
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CD40 ligand and appropriate cytokines induce switching to IgG, IgA, and IgE and coordinated germinal center and plasmacytoid phenotypic differentiation in a human monoclonal IgM+IgD+ B cell line.
    Cerutti A; Zan H; Schaffer A; Bergsagel L; Harindranath N; Max EE; Casali P
    J Immunol; 1998 Mar; 160(5):2145-57. PubMed ID: 9498752
    [TBL] [Abstract][Full Text] [Related]  

  • 50. IL-3 and granulocyte-macrophage colony-stimulating factor strongly induce Ig secretion by sort-purified murine B cell activated through the membrane Ig, but not the CD40, signaling pathway.
    Snapper CM; Moorman MA; Rosas FR; Kehry MR; Maliszewski CR; Mond JJ
    J Immunol; 1995 Jun; 154(11):5842-50. PubMed ID: 7538533
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Surface immunoglobulin ligands and cytokines differentially affect proliferation and antibody production by human CD5+ and CD5- B lymphocytes.
    Nawata Y; Stall AM; Herzenberg LA; Eugui EM; Allison AC
    Int Immunol; 1990; 2(7):603-14. PubMed ID: 1703783
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CD40 and IgE: synergism between anti-CD40 monoclonal antibody and interleukin 4 in the induction of IgE synthesis by highly purified human B cells.
    Jabara HH; Fu SM; Geha RS; Vercelli D
    J Exp Med; 1990 Dec; 172(6):1861-4. PubMed ID: 1701824
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diminished expression of CD40 ligand may contribute to the defective humoral immunity in patients with MHC class II deficiency.
    Nonoyama S; Etzioni A; Toru H; Ruggerie DP; Lewis D; Pollack S; Aruffo A; Yata JI; Ochs HD
    Eur J Immunol; 1998 Feb; 28(2):589-98. PubMed ID: 9521069
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Induction by anti-CD40 antibody or soluble CD40 ligand and cytokines of IgG, IgA and IgE production by B cells from patients with X-linked hyper IgM syndrome.
    Durandy A; Schiff C; Bonnefoy JY; Forveille M; Rousset F; Mazzei G; Milili M; Fischer A
    Eur J Immunol; 1993 Sep; 23(9):2294-9. PubMed ID: 7690328
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The ADP-ribosylating CTA1-DD adjuvant enhances T cell-dependent and independent responses by direct action on B cells involving anti-apoptotic Bcl-2- and germinal center-promoting effects.
    Agren L; Sverremark E; Ekman L; Schön K; Löwenadler B; Fernandez C; Lycke N
    J Immunol; 2000 Jun; 164(12):6276-86. PubMed ID: 10843681
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of CD40-CD40 ligand interaction in human T cell-B cell collaboration.
    Nishioka Y; Lipsky PE
    J Immunol; 1994 Aug; 153(3):1027-36. PubMed ID: 7517971
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CD40 stimulation of human peripheral B lymphocytes: distinct response from naive and memory cells.
    Fecteau JF; Néron S
    J Immunol; 2003 Nov; 171(9):4621-9. PubMed ID: 14568936
    [TBL] [Abstract][Full Text] [Related]  

  • 58. B cell differentiation defects in common variable immunodeficiency are ameliorated after stimulation with anti-CD40 antibody and IL-10.
    Eisenstein EM; Chua K; Strober W
    J Immunol; 1994 Jun; 152(12):5957-68. PubMed ID: 7515919
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-vs-host disease.
    Durie FH; Aruffo A; Ledbetter J; Crassi KM; Green WR; Fast LD; Noelle RJ
    J Clin Invest; 1994 Sep; 94(3):1333-8. PubMed ID: 7521888
    [TBL] [Abstract][Full Text] [Related]  

  • 60. IgM and IgG but not cytokine secretion is restricted to the CD27+ B lymphocyte subset.
    Maurer D; Fischer GF; Fae I; Majdic O; Stuhlmeier K; Von Jeney N; Holter W; Knapp W
    J Immunol; 1992 Jun; 148(12):3700-5. PubMed ID: 1318333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.